Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue grew 17.2%, EPS grew 36.4% and free cash flow fell 3.03%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for ten.

618.47 10.13 −1.61%
Market cap
$17.6B
P/E
35.6×
Fwd P/E
26.7×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
9 9 8 8

+8 more TTM periods

ROE
162.15% 77.25% 70.23% 73.71%
ROA
27.09% 22.87% 22.13% 22.57%
ROIC
0.00% 0.00% 0.00% 3,822.71%
Return on Tangible Assets
(215.54%) (663.29%) (202.23%) (104.74%)
Average Days of Receivables
57.96 53.77 58.00 57.73
Free Cash Flow per Share
25.08 25.00 23.64 24.05
Free Cash Flow
706.69 711.00 681.87 676.77
Other line items

Show all line items

Columns are period end dates